Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04344587 |
Recruitment Status :
Completed
First Posted : April 14, 2020
Last Update Posted : November 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Prone positioning is a well studied and validated treatment for severe acute respiratory distress syndrome (ARDS), however there are no randomized studies on the use of prone positioning in the non-intubated patient. It is unknown if this intervention would be helpful in preventing further respiratory deterioration in terms of increasing supplemental oxygen requirements, endotracheal intubation, and ICU admission.
The Awake Prone Position for Early hypoxemia in COVID-19 (APPEX-19) Study is a pragmatic adaptive randomized controlled unblinded trial. APPEX-19 randomizes non-ICU patients with COVID-19 or who are under evaluation for COVID-19 to lie in a prone position (i.e, with their stomach and chest facing down) or to usual care.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
COVID-19 | Other: Self-prone position recommendation Other: Usual care | Not Applicable |
The purpose of this multi-site trial is to investigate the use of prone positioning in SARS-CoV-2 infected patients who are not intubated. The APPEX-19 study is a pragmatic adaptive randomized controlled unblinded trial. The study compares a smartphone tool that recommends non-ICU patients with COVID-19 or who are under evaluation for COVID-19 to lie in a prone position (i.e, with their stomach and chest facing down) to usual care.
Participants who are assigned to the intervention arm will receive a text message containing a link to an online website that reviews how to safely self-prone position and a recommendation to self-prone position 4 times for 1-2 hours each during the day and at night every 24 hours. Participants will also receive twice daily reminders to self-prone using the same smartphone platform.
All participants will receive twice daily Qualtrics online surveys to answer questions about which body positions they used in bed and their level of comfort and shortness of breath. Participants will receive these twice daily text messages until they are discharged, until they are transferred to the ICU, until they die, until their lung function declines, or until 14 days pass since enrollment. Thus, most participants will receive twice daily text messages for about 1 week; it is expected that almost all patients will receive twice daily text messages for no longer than 14 days. Medical charts will be reviewed daily to track routine clinical data to determine outcomes.
Boston Medical Center (BMC) / Boston University will be one of the 16 sites and the data coordinating center for this multisite trial. The unique design of the study means that if evidence accumulates that one treatment is better than the other, more participants will be chosen to receive the prone position intervention that works over time. Thus, the trial will both show what works, implement what works, and make sure that the most participants receive the treatment that works.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 305 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Awake Prone Position for Early Hypoxemia in COVID-19 |
Actual Study Start Date : | April 23, 2020 |
Actual Primary Completion Date : | May 7, 2021 |
Actual Study Completion Date : | May 7, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention group
Participants in the intervention arm will receive a text message on their smartphones linking to the Qualtrics intervention website
|
Other: Self-prone position recommendation
The Qualtrics self-prone position recommendation intervention website will include the following sections:
|
Active Comparator: Usual care group
Participants in the usual care arm will receive a text message on their smartphone linking to the Qualtrics usual care website
|
Other: Usual care
The Qualtrics usual care website will include the following sections:
|
- Change in respiratory status [ Time Frame: up to 30 days ]Change in respiratory status will be defined as:1) admission to the ICU and/or a 2) an increase in supplemental oxygen delivery (defined as an increase in oxygen delivery rate of ≥2 liter per minute compared to the oxygen delivery rate at the time of intervention or usual care text message that is sustained for ≥12 or more hours OR the switch to an oxygen delivery method that increases the level of supplemental oxygen.
- Length of time participant spends in the prone position [ Time Frame: up to 30 days ]Length of time in the prone position will be assessed from the smartphone survey and measured in categories of no time, up to 6 hours, 6 hours to 11 hours, 12 hours or more.
- Length of time participant spends in the supine position [ Time Frame: up to 30 days ]Length of time in the supine/lying on back position will be assessed from the smartphone survey and measured in categories of no time, up to 6 hours, 6 hours to 11 hours, 12 hours or more.
- Length of time participant spends lying on side [ Time Frame: up to 30 days ]Length of time lying on side will be assessed from the smartphone survey and measured in categories of no time, up to 6 hours, 6 hours to 11 hours, 12 hours or more.
- Length of time participant spends sitting up [ Time Frame: up to 30 days ]Length of time sitting up will be assessed from the smartphone survey and measured in categories of no time, up to 6 hours, 6 hours to 11 hours, 12 hours or more.
- Length of time participant spends standing or walking [ Time Frame: up to 30 days ]Length of time standing or walking will be assessed from the smartphone survey and measured in categories of no time, up to 6 hours, 6 hours to 11 hours, 12 hours or more.
- Dyspnea or difficult/labored breathing [ Time Frame: up to 30 days ]Dyspnea will be assessed by the modified Borg Dyspnea Score (10-point ordinal scale) from 1= nothing at all to 10= maximal. Higher scores indicate more dyspnea.
- Discomfort with proning [ Time Frame: up to 30 days ]Discomfort with proning (4-point ordinal scale: very comfortable, somewhat comfortable, somewhat uncomfortable, very uncomfortable)
- Length of hospital stay [ Time Frame: up to 30 days ]Total number of days hospitalized will be abstracted from the electronic medical record.
- Invasive mechanical ventilation [ Time Frame: up to 30 days ]Invasive mechanical ventilation will be abstracted from the electronic medical record.
- Loss of IV access as a consequence of turning in bed [ Time Frame: up to 30 days ]Loss of IV access as a consequence of turning in bed will be reported by participant using monitoring surveys
- Acute respiratory distress syndrome (ARDS) diagnosis [ Time Frame: up to 30 days ]ARDS diagnosis will be abstracted from the electronic medical record
- Hospital mortality [ Time Frame: up to 30 days ]Hospital mortality will be abstracted from the electronic medical record

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Assigned to or admitted to a COVID-19 ward team at a participating site (these teams only admit patients who are under investigation for COVID-19 or who have confirmed COVID-19 infection) via the emergency department (ED) within the last 24 hours
- Have access to their own functioning smartphone in the hospital room
- English or Spanish-speaking
- Ability to read simple instructions and answer simple written questions
Exclusion Criteria:
Baseline patient factors
- Inability to operate the hospital bed
- Inability to lie flat comfortably
- Inability to lie flat without shortness of breath
- Inability to turn over independently
Medical comorbidities
- Hemoptysis in the last 2 days
- Prior lung transplant
- Dementia
Acute issues
- Deep venous thrombosis treated for less than 2 days
- Unstable spine, femur, or pelvic fractures
- Mean arterial pressure lower than 65 mmHg
- Receiving ≥6 liters per minute of supplemental oxygen via nasal cannula, nasal pendant, or shovel mask
- Receiving supplemental oxygen via more aggressive methods (e.g. Venturi mask or non-rebreather mask)
Recent interventions
- Chest tube in place
- Tracheal surgery or sternotomy during the previous 15 days
- Serious facial trauma or facial surgery during the previous 15 days
- Cardiac pacemaker inserted in the last 2 days
Other
- Pregnancy
- Comfort measures only status
- Prisoner

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04344587
United States, California | |
Long Beach Medical Center - MemorialCare | |
Long Beach, California, United States, 90806 | |
Alvarado Hospital | |
San Diego, California, United States, 92120 | |
United States, Colorado | |
St. Joseph's Hospital National Jewish Health | |
Denver, Colorado, United States, 80218 | |
United States, District of Columbia | |
MedStar Georgetown University Hospital | |
Washington, District of Columbia, United States, 20007 | |
United States, Georgia | |
Piedmont Atlanta | |
Atlanta, Georgia, United States, 30309 | |
United States, Iowa | |
University of Iowa Hospitals and Clinics | |
Iowa City, Iowa, United States, 52242 | |
United States, Kansas | |
University of Kansas Medical Center | |
Kansas City, Kansas, United States, 66160 | |
United States, Massachusetts | |
Boston Medical Center | |
Boston, Massachusetts, United States, 02118 | |
United States, Michigan | |
University of Michigan | |
Ann Arbor, Michigan, United States, 48109 | |
United States, Nebraska | |
Creighton University | |
Omaha, Nebraska, United States, 68178 | |
United States, Texas | |
Michael E. DeBakey Veteran Affairs Medical Center | |
Houston, Texas, United States, 77030 | |
United States, Virginia | |
VCU Medical Center | |
Richmond, Virginia, United States, 23219 | |
Spain | |
Hospital Universitario La Paz | |
Madrid, Spain, 28049 |
Study Director: | Allan J Walkey, MD | Boston University |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Boston University |
ClinicalTrials.gov Identifier: | NCT04344587 |
Other Study ID Numbers: |
H-40070 |
First Posted: | April 14, 2020 Key Record Dates |
Last Update Posted: | November 1, 2021 |
Last Verified: | October 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Prone position Coronavirus Inhalation oxygen therapy Pragmatic Clinical Tria Hypoxia |
COVID-19 Hypoxia Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia Virus Diseases |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases Signs and Symptoms, Respiratory |